Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
UTMD logo UTMD
Upturn stock ratingUpturn stock rating
UTMD logo

Utah Medical Products Inc (UTMD)

Upturn stock ratingUpturn stock rating
$56
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

04/01/2025: UTMD (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -45.22%
Avg. Invested days 23
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 04/01/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 183.78M USD
Price to earnings Ratio 14.14
1Y Target Price -
Price to earnings Ratio 14.14
1Y Target Price -
Volume (30-day avg) 17626
Beta 0.06
52 Weeks Range 55.80 - 76.21
Updated Date 04/1/2025
52 Weeks Range 55.80 - 76.21
Updated Date 04/1/2025
Dividends yield (FY) 2.17%
Basic EPS (TTM) 3.96

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 33.92%
Operating Margin (TTM) 35.67%

Management Effectiveness

Return on Assets (TTM) 7.62%
Return on Equity (TTM) 11.29%

Valuation

Trailing PE 14.14
Forward PE -
Enterprise Value 101143696
Price to Sales(TTM) 4.57
Enterprise Value 101143696
Price to Sales(TTM) 4.57
Enterprise Value to Revenue 2.56
Enterprise Value to EBITDA 6.36
Shares Outstanding 3281820
Shares Floating 2826694
Shares Outstanding 3281820
Shares Floating 2826694
Percent Insiders 7.12
Percent Institutions 72.87

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Utah Medical Products Inc

stock logo

Company Overview

overview logo History and Background

Utah Medical Products, Inc. was founded in 1978. It designs, develops, manufactures, and markets a broad range of disposable and reusable specialty medical devices, primarily for the care of women and their babies.

business area logo Core Business Areas

  • Labor & Delivery: Products designed to improve the safety and efficiency of childbirth, including fetal monitoring catheters and vacuum delivery systems.
  • Electrosurgical Products & Accessories: Products include electrosurgical loops and electrodes used in LEEP (Loop Electrosurgical Excision Procedure) for the treatment of cervical dysplasia.
  • Other Specialty Products: Encompasses various products such as those used for neonatal care, including umbilical vessel catheters and pressure monitoring devices.

leadership logo Leadership and Structure

Kevin Cornwell is the CEO. The company has a board of directors and operates through distinct departments focusing on manufacturing, sales, and research & development.

Top Products and Market Share

overview logo Key Offerings

  • Fetal Monitoring Catheters: These catheters monitor the fetal heart rate and uterine contractions during labor. Market share data is not readily available for just Utah Medical Products. Competitors include CooperSurgical and Medtronic.
  • Vacuum Delivery Systems: Used to assist in childbirth when complications arise. Market share data is not readily available for just Utah Medical Products. Competitors include CooperSurgical and Kiwi Medical.
  • LEEP Products: Electrosurgical loops and electrodes used to treat cervical dysplasia. Market share data is not readily available for just Utah Medical Products. Competitors include CooperSurgical and Bovie Medical.

Market Dynamics

industry overview logo Industry Overview

The medical device industry is driven by technological advancements, an aging population, and increasing healthcare spending. It is highly regulated and competitive.

Positioning

Utah Medical Products focuses on niche markets within women's and infant's health, emphasizing product innovation and high-quality manufacturing, leading to a strong reputation for quality and safety. Their competitive advantage is their specialization and focus on specific medical needs.

Total Addressable Market (TAM)

The global medical device market is in the billions of dollars. Utah Medical Products focuses on niche markets; their TAM is a subset of the overall medical device market, particularly within obstetrics and gynecology. The company's market share is relatively small compared to the overall medical device TAM, but strategically positioned within its specific segments.

Upturn SWOT Analysis

Strengths

  • Specialized product portfolio
  • Strong brand reputation for quality
  • Focus on niche markets
  • Established distribution network
  • High profit margins

Weaknesses

  • Limited product diversification
  • Dependence on specific market segments
  • Smaller size compared to major competitors
  • Vulnerability to regulatory changes
  • Geographic concentration of revenue

Opportunities

  • Expanding into new geographic markets
  • Developing innovative products
  • Acquiring complementary businesses
  • Leveraging technological advancements
  • Increasing demand for minimally invasive procedures

Threats

  • Increased competition
  • Product liability claims
  • Healthcare cost containment pressures
  • Changing regulatory landscape
  • Economic downturns

Competitors and Market Share

competitor logo Key Competitors

  • COOP
  • MDT

Competitive Landscape

Utah Medical Products competes in niche segments with larger companies, but it maintains competitive advantages through specialization, innovation, and a reputation for quality.

Major Acquisitions

Femcare Ltd.

  • Year: 2007
  • Acquisition Price (USD millions): 2.4
  • Strategic Rationale: Acquired the assets and manufacturing rights to certain products used in conjunction with uterine aspiration.

Growth Trajectory and Initiatives

Historical Growth: Utah Medical Products growth historically has been steady but not explosive, driven by niche product success and strategic acquisitions. Reference SEC filings for exact historical values.

Future Projections: Analyst estimates vary, but future growth is expected to be driven by expansion into new markets, innovative product development, and potential acquisitions. Analyst estimates are not directly available in this structured format.

Recent Initiatives: Recent strategic initiatives may include new product launches, geographic expansion efforts, or acquisitions of smaller companies.

Summary

Utah Medical Products is a niche player in the medical device industry focusing on women's and infant's health. It has a strong reputation for product quality and high profit margins, but it is more vulnerable to competition than larger, more diversified peers. Geographic revenue concentration is an area to watch. The company has a good track record of strategic acquisitions for growth.

Similar Companies

  • COOP
  • BWAY
  • LEMO

Sources and Disclaimers

Data Sources:

  • SEC Filings
  • Company Website
  • Financial News Articles
  • Industry Reports

Disclaimers:

The information provided is for informational purposes only and does not constitute financial advice. Market share estimates are approximate and may vary. Financial data is based on publicly available information and may be subject to change.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Utah Medical Products Inc

Exchange NASDAQ
Headquaters Midvale, UT, United States
IPO Launch date 1999-03-08
Chairman, CEO, President & Secretary Mr. Kevin L. Cornwell
Sector Healthcare
Industry Medical Instruments & Supplies
Full time employees 155
Full time employees 155

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO, an umbilical vessel catheters, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation devices; suprapubic catheterization; LIBERTY, an urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​